• 1
    Malik B, Nie D. Cancer stem cells and resistance to chemo and radio therapy. Front Biosci (Elite Ed) 2012; 4: 21422149.
  • 2
    Stupp R, Mason WP, van den Bent MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987996.
  • 3
    Chen J, Li Y, Yu TS et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012; 488: 522526.
  • 4
    Singh SK, Hawkins C, Clarke ID et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396401.
  • 5
    Liu G, Yuan X, Zeng Z et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006; 5: 67.
  • 6
    Phillips TM, McBride WH, Pajonk F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 2006; 98: 17771785.
  • 7
    Bao S, Wu Q, McLendon RE et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444: 756760.
  • 8
    Kim MJ, Kim RK, Yoon CH et al. Importance of PKCdelta signaling in fractionated-radiation-induced expansion of glioma-initiating cells and resistance to cancer treatment. J Cell Sci 2011; 124: 30843094.
  • 9
    Diehn M, Clarke MF. Cancer stem cells and radiotherapy: New insights into tumor radioresistance. J Natl Cancer Inst 2006; 98: 17551757.
  • 10
    Woodward WA, Chen MS, Behbod F et al. WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci USA 2007; 104: 618623.
  • 11
    Tamura K, Aoyagi M, Wakimoto H et al. Accumulation of CD133-positive glioma cells after high-dose irradiation by Gamma Knife surgery plus external beam radiation. J Neurosurg 2010; 113: 310318.
  • 12
    Bensimon J, Altmeyer-Morel S, Benjelloun H et al. CD24(-/low) stem-like breast cancer marker defines the radiation-resistant cells involved in memorization and transmission of radiation-induced genomic instability. Oncogene 2013; 32: 251258.
  • 13
    Vlashi E, Kim K, Lagadec C et al. In vivo imaging, tracking, and targeting of cancer stem cells. J Natl Cancer Inst 2009; 101: 350359.
  • 14
    Wang J, Wakeman TP, Lathia JD et al. Notch promotes radioresistance of glioma stem cells. Stem Cells 2010; 28: 1728.
  • 15
    Reguart N, He B, Taron M et al. The role of Wnt signaling in cancer and stem cells. Future Oncol 2005; 1: 787797.
  • 16
    Hsieh A, Ellsworth R, Hsieh D. Hedgehog/GLI1 regulates IGF dependent malignant behaviors in glioma stem cells. J Cell Physiol 2011; 226: 11181127.
  • 17
    Hatanpaa KJ, Burma S, Zhao D et al. Epidermal growth factor receptor in glioma: Signal transduction, neuropathology, imaging, and radioresistance. Neoplasia 2010; 12: 675684.
  • 18
    Sharma SV, Lee DY, Li B et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 2010; 141: 6980.
  • 19
    Dallas NA, Xia L, Fan F et al. Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res 2009; 69: 19511957.
  • 20
    Eckstein N, Servan K, Hildebrandt B et al. Hyperactivation of the insulin-like growth factor receptor I signaling pathway is an essential event for cisplatin resistance of ovarian cancer cells. Cancer Res 2009; 69: 29963003.
  • 21
    Buck E, Eyzaguirre A, Rosenfeld-Franklin M et al. Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors. Cancer Res 2008; 68: 83228332.
  • 22
    Turner BC, Haffty BG, Narayanan L et al. Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res 1997; 57: 30793083.
  • 23
    Macaulay VM, Salisbury AJ, Bohula EA et al. Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of Atm kinase. Oncogene 2001; 20: 40294040.
  • 24
    Bartucci M, Morelli C, Mauro L et al. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Cancer Res 2001; 61: 67476754.
  • 25
    Robbins DJ, Cheng M, Zhen E et al. Evidence for a Ras-dependent extracellular signal-regulated protein kinase (ERK) cascade. Proc Natl Acad Sci USA 1992; 89: 69246928.
  • 26
    Valenciano A, Henriquez-Hernandez LA, Moreno M et al. Role of IGF-1 receptor in radiation response. Transl Oncol 2012; 5: 19.
  • 27
    Medyouf H, Gusscott S, Wang H et al. High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling. J Exp Med 2011; 208: 18091822.
  • 28
    Qiu W, Leibowitz B, Zhang L et al. Growth factors protect intestinal stem cells from radiation-induced apoptosis by suppressing PUMA through the PI3K/AKT/p53 axis. Oncogene 2010; 29: 16221632.
  • 29
    Sampetrean O, Saga I, Nakanishi M et al. Invasion precedes tumor mass formation in a malignant brain tumor model of genetically modified neural stem cells. Neoplasia 2011; 13: 784791.
  • 30
    Shimizu T, Ishikawa T, Sugihara E et al. c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis. Oncogene 2010; 29: 56875699.
  • 31
    Fujino RS, Tanaka K, Morimatsu M et al. Spermatogonial cell-mediated activation of an IkappaBzeta-independent nuclear factor-kappaB pathway in Sertoli cells induces transcription of the lipocalin-2 gene. Mol Endocrinol 2006; 20: 904915.
  • 32
    Yuan X, Curtin J, Xiong Y et al. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 2004; 23: 93929400.
  • 33
    Bao S, Wu Q, Sathornsumetee S et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 2006; 66: 78437848.
  • 34
    Todaro M, Alea MP, Di Stefano AB et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 2007; 1: 389402.
  • 35
    Todaro M, Perez Alea M, Scopelliti A et al. IL-4-mediated drug resistance in colon cancer stem cells. Cell Cycle 2008; 7: 309313.
  • 36
    Tang KH, Ma S, Lee TK et al. CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling. Hepatology 2012; 55: 807820.
  • 37
    Trojan J, Blossey BK, Johnson TR et al. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I. Proc Natl Acad Sci USA 1992; 89: 48744878.
  • 38
    Trojan J, Johnson TR, Rudin SD et al. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science 1993; 259: 9497.
  • 39
    Trojan J, Duc HT, Upegui-Gonzalez LC et al. Presence of MHC-I and B-7 molecules in rat and human glioma cells expressing antisense IGF-I mRNA. Neurosci Lett 1996; 212: 912.
  • 40
    Brunet A, Bonni A, Zigmond MJ et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96: 857868.
  • 41
    Daitoku H, Sakamaki J, Fukamizu A. Regulation of FoxO transcription factors by acetylation and protein-protein interactions. Biochim Biophys Acta 2011; 1813: 19541960.
  • 42
    Brownawell AM, Kops GJ, Macara IG et al. Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. Mol Cell Biol 2001; 21: 35343546.
  • 43
    van den Berg MC, Burgering BM. Integrating opposing signals toward Forkhead box O. Antioxid Redox Signal 2011; 14: 607621.
  • 44
    Reagan-Shaw S, Ahmad N. The role of Forkhead-box Class O (FoxO) transcription factors in cancer: A target for the management of cancer. Toxicol Appl Pharmacol 2007; 224: 360368.
  • 45
    Renault VM, Rafalski VA, Morgan AA et al. FoxO3 regulates neural stem cell homeostasis. Cell Stem Cell 2009; 5: 527539.
  • 46
    Diehn M, Cho RW, Lobo NA et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009; 458: 780783.
  • 47
    Beier D, Hau P, Proescholdt M et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 2007; 67: 40104015.
  • 48
    Magee JA, Piskounova E, Morrison SJ. Cancer stem cells: Impact, heterogeneity, and uncertainty. Cancer Cell 2012; 21: 283296.
  • 49
    Muerkoster S, Wegehenkel K, Arlt A et al. Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta. Cancer Res 2004; 64: 13311337.
  • 50
    Ivanov VN, Zhou H, Ghandhi SA et al. Radiation-induced bystander signaling pathways in human fibroblasts: A role for interleukin-33 in the signal transmission. Cell Signal 2010; 22: 10761087.
  • 51
    Hellawell GO, Turner GD, Davies DR et al. Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease. Cancer Res 2002; 62: 29422950.
  • 52
    All-Ericsson C, Girnita L, Seregard S et al. Insulin-like growth factor-1 receptor in uveal melanoma: A predictor for metastatic disease and a potential therapeutic target. Invest Ophthalmol Vis Sci 2002; 43: 18.
  • 53
    Nickerson T, Chang F, Lorimer D et al. In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR). Cancer Res 2001; 61: 62766280.
  • 54
    Yu D, Watanabe H, Shibuya H et al. Redundancy of radioresistant signaling pathways originating from insulin-like growth factor I receptor. J Biol Chem 2003; 278: 67026709.
  • 55
    Iwasa T, Okamoto I, Suzuki M et al. Inhibition of insulin-like growth factor 1 receptor by CP-751,871 radiosensitizes non-small cell lung cancer cells. Clin Cancer Res 2009; 15: 51175125.
  • 56
    Wang YH, Wang ZX, Qiu Y et al. Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits growth, reduces invasion, and enhances radiosensitivity in human osteosarcoma cells. Mol Cell Biochem 2009; 327: 257266.
  • 57
    Allen GW, Saba C, Armstrong EA et al. Insulin-like growth factor-I receptor signaling blockade combined with radiation. Cancer Res 2007; 67: 11551162.
  • 58
    Yavari K, Taghikhani M, Maragheh MG et al. SiRNA-mediated IGF-1R inhibition sensitizes human colon cancer SW480 cells to radiation. Acta Oncol 2010; 49: 7075.
  • 59
    Cosaceanu D, Carapancea M, Castro J et al. Modulation of response to radiation of human lung cancer cells following insulin-like growth factor 1 receptor inactivation. Cancer Lett 2005; 222: 173181.
  • 60
    Friedlander TW, Weinberg VK, Huang Y et al. A phase II study of insulin-like growth factor receptor inhibition with nordihydroguaiaretic acid in men with non-metastatic hormone-sensitive prostate cancer. Oncol Rep 2012; 27: 39.
  • 61
    Quek R, Wang Q, Morgan JA et al. Combination mTOR and IGF-1R inhibition: Phase I trial of everolimus and figitumumab in patients with advanced sarcomas and other solid tumors. Clin Cancer Res 2011; 17: 871879.